...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Myeloid malignancies and the microenvironment
【24h】

Myeloid malignancies and the microenvironment

机译:骨髓恶性肿瘤和微环境

获取原文
获取原文并翻译 | 示例

摘要

Research in the last few years has revealed a sophisticated interaction network between multiple bone marrow cells that regulate different hematopoietic stem cell (HSC) properties such as proliferation, differentiation, localization, and self-renewal during homeostasis. These mechanisms are essential to keep the physiological HSC numbers in check and interfere with malignant progression. In addition to the identification of multiple mutations and chromosomal aberrations driving the progression of myeloid malignancies, alterations in the niche compartment recently gained attention for contributing to disease progression. Leukemic cells can remodel the niche into a permissive environment favoring leukemic stem cell expansion over normal HSC maintenance, and evidence is accumulating that certain niche alterations can even induce leukemic transformation. Relapse after chemotherapy is still amajor challenge during treatment of myeloid malignancies, and cure is only rarely achieved. Recent progress in understanding the nicheimposed chemoresistancemechanisms will likely contribute to the improvement of current therapeutic strategies. This article discusses the role of different niche cells and their stage-and disease-specific roles during progression of myeloid malignancies and in response to chemotherapy.
机译:过去几年的研究揭示了多个骨髓细胞之间的复杂相互作用网络,其调节不同造血干细胞(HSC)性质,例如稳态期间的增殖,分化,定位和自我更新。这些机制对于保持生理HSC编号必须检查并干扰恶性进展至关重要。除了鉴定驱动骨髓恶性肿瘤进展的多种突变和染色体像差外,利基室内的改变最近促进了疾病进展的关注。白血病细胞可以将利基改造为有利于白血症干细胞扩张的允许环境在正常的HSC维护上,并且证据积累了某些乳蛋白的改变甚至可以诱导白血病转化。化疗后复发仍然是在治疗骨髓恶性肿瘤的治疗过程中仍然是挑战,并且只有很少实现治疗。最近在理解利基化学化学钻石机制的进展可能有助于改善当前的治疗策略。本文讨论了在骨髓恶性肿瘤的进展过程中不同育细胞和其阶段和疾病特异性作用的作用,并响应化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号